At a glance
The April 6, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology tests, answers to submitted questions, CLIA guidance, hospital systems during the COVID-19 response, Nebraska's public health laboratory response, reporting testing data to CDC, and biosafety.
Agenda
Archived LOCS Materials Access
Welcome and Introductions: Jasmine Chaitram, CDC Division of Laboratory Systems
Performance Evaluation of Commercially Developed Serology Tests: Michele Owen, CDC Laboratory Task Force
Updates and Responses to Submitted Questions on Diagnostics and Testing: Tim Stenzel, U.S. Food and Drug Administration (FDA)
Additional CLIA Guidance for Testing Laboratories: Karen Dyer, Centers for Medicare & Medicaid Services (CMS)
COVID-19 Response – Hospital System on the Front Lines: James (Jim) Crawford, Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellHealth, Lake Success, New York
Nebraska's Public Health Laboratory Response: Peter Iwen, Nebraska State Public Health Laboratory
Reporting Testing Data to CDC: Jasmine Chaitram, CDC Division of Laboratory Systems
Laboratory Biosafety Update for COVID-19: Bill Arndt, CDC Division of Laboratory Systems
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.